{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T02:23:05Z","timestamp":1768270985234,"version":"3.49.0"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Diffuse large B-cell lymphoma (DLBCL) and chronic lymphocytic leukemia (CLL) are subtypes of non-Hogkin lymphoma (NHL) that are generally distinct form one cases, but the transformation of one of these diseases into the other is possible. Some patients with CLL, for instance, have the potential to develop Richter transformation such that they are diagnosed with a rare, invasive DLBCL subtype. In this study, bioinformatics analyses of these two NHL subtypes were conducted, identifying key patterns of gene expression and then experimentally validating the results. Disease-related gene expression datasets from the GEO database were used to identify differentially expressed genes (DEGs) and DEG functions were examined using GO analysis and protein-protein interaction network construction. This strategy revealed many up- and down-regulated DEGs, with functional enrichment analyses identifying these genes as being closely associated with inflammatory and immune response activity. PPI network analyses and the evaluation of clustered network modules indicated the top 10 up- and down-regulated genes involved in disease onset and development. Serological analyses revealed significantly higher ALB, TT, and WBC levels in CLL patients relative to DLBCL patients, whereas the opposite was true with respect to TG, HDL, GGT, ALP, ALT, and NEUT% levels. In comparison to the CLL and DLBCL groups, the healthy control samples demonstrated higher signals of protein peak positions (621, 643, 848, 853, 869, 935, 1003, 1031, 1221, 1230, 1260, 1344, 1443, 1446, 1548, 1579, 1603, 1647 cm<jats:sup>-1<\/jats:sup>), nucleic acid peak positions (726, 781, 786, 1078, 1190, 1415, 1573, 1579 cm<jats:sup>-1<\/jats:sup>), beta carotene peak positions (957, 1155, 1162 cm<jats:sup>-1<\/jats:sup>), carbohydrate peak positions (842 cm<jats:sup>-1<\/jats:sup>), collagen peak positions (1345 cm<jats:sup>-1<\/jats:sup>), and lipid peak positions (957, 1078, 1119, 1285, 1299, 1437, 1443, 1446 cm<jats:sup>-1<\/jats:sup>) compared to the CLL and DLBCL groups. Verification of these key genes in patient samples yielded results consistent with findings derived from bioinformatics analyses, highlighting their relevance to diagnosing and treating these forms of NHL. Together, these analyses identified genes and pathways involved in both DLBCL and CLL. The set of molecular markers established herein can aid in patient diagnosis and prognostic evaluation, providing a valuable foundation for their therapeutic application.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1516946","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T06:54:53Z","timestamp":1740466493000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Raman spectroscopy and bioinformatics-based identification of key genes and pathways capable of distinguishing between diffuse large B cell lymphoma and chronic lymphocytic leukemia"],"prefix":"10.3389","volume":"16","author":[{"given":"Haoyue","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yansong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanfan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030835","article-title":"The immunology of DLBCL","volume":"15","author":"Takahara","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: A report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.05.002","article-title":"Syk inhibition modulates distinct pi3k\/akt- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomas","volume":"23","author":"Chen","year":"2013","journal-title":"Cancer Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.242701","article-title":"The process of somatic hypermutation increases polyreactivity for central nervous system antigens in primary central nervous system lymphoma","volume":"106","author":"Montesinos-Rongen","year":"2021","journal-title":"Haematologica"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9440(10)65526-5","article-title":"Primary central nervous system lymphomas are derived from germinal-center B cells and show A preferential usage of the V4-34 gene segment","volume":"155","author":"Montesinos-Rongen","year":"1999","journal-title":"Am J Pathol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/pas.0000000000001809","article-title":"Clinicopathologic Analysis of Primary Adrenal Diffuse Large B-Cell Lymphoma: A Reappraisal of 23 Japanese Patients based on EBV Association and Pd-L1 Expression in Tumor cells","volume":"45","author":"Kawano","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic immunity in cancer","volume":"21","author":"Hiam-Galvez","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1595","article-title":"A prognostic model, including the EBV status of tumor cells, for primary gastric diffuse large B-cell lymphoma in the rituximab era","volume":"7","author":"Ishikawa","year":"2018","journal-title":"Cancer Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1875","article-title":"Clinicopathological analysis of primary intestinal diffuse large B-cell lymphoma: prognostic evaluation of cd5, pd-L1, and epstein-barr virus on tumor cells","volume":"7","author":"Ishikawa","year":"2018","journal-title":"Cancer Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/pas.0000000000001499","article-title":"Reappraisal of primary epstein-barr virus (EBV)-positive diffuse large B-cell lymphoma of the gastrointestinal tract: comparative analysis among immunosuppressed and nonimmunosuppressed stage I and II-IV patients","volume":"44","author":"Miyagi","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258423","article-title":"Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal-results from a population-based cancer registry cohort study","volume":"16","author":"Cardoso Borges","year":"2021","journal-title":"PloS One"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1858293","article-title":"Epidemiology, longitudinal treatment patterns and outcomes of chronic lymphocytic leukemia in Israel","volume":"62","author":"Weil","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13102468","article-title":"Current treatment options in cll","volume":"13","author":"Bewarder","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081782","article-title":"From biomarkers to models in the changing landscape of chronic lymphocytic leukemia: evolve or become extinct","volume":"13","author":"Gonz\u00e1lez-Gasc\u00f3n","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2021.01.006","article-title":"The future of laboratory testing in chronic lymphocytic leukaemia","volume":"53","author":"Hotinski","year":"2021","journal-title":"Pathology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.594556","article-title":"Immune dysfunctions and immune-based therapeutic interventions in chronic lymphocytic leukemia","volume":"11","author":"Griggio","year":"2020","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2015.07.009","article-title":"Microenvironment interactions and B-cell receptor signaling in chronic lymphocytic leukemia: implications for disease pathogenesis and treatment","volume":"1863","author":"Ten Hacken","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092614","article-title":"High M-mdsc percentage as a negative prognostic factor in chronic lymphocytic leukaemia","volume":"12","author":"Zarobkiewicz","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-567388","article-title":"Perturbation of the normal immune system in patients with cll","volume":"126","author":"Forconi","year":"2015","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.267914","article-title":"T-cell dysfunction in chronic lymphocytic leukemia from an epigenetic perspective","volume":"106","author":"Peters","year":"2021","journal-title":"Haematologica"},{"key":"B23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.semcancer.2013.08.011","article-title":"The microenvironment in chronic lymphocytic leukemia (Cll) and other B cell Malignancies: insight into disease biology and new targeted therapies","volume":"24","author":"Burger","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13133255","article-title":"T cell defects and immunotherapy in chronic lymphocytic leukemia","volume":"13","author":"Vlachonikola","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11899-019-00512-0","article-title":"Targeting btk in CLL: beyond ibrutinib","volume":"14","author":"Bond","year":"2019","journal-title":"Curr Hematol Malig Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0010-1","article-title":"Determinants of response and resistance to cd19 chimeric antigen receptor (Car) T cell therapy of chronic lymphocytic leukemia","volume":"24","author":"Fraietta","year":"2018","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2010.3522","article-title":"Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants","volume":"15","author":"Cook-Mills","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/ar1717","article-title":"Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis","volume":"7","author":"Dessein","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2004.09.027","article-title":"Upregulation of endothelial adhesion molecules in hearts with congestive and ischemic cardiomyopathy: immunohistochemical evaluation of inflammatory endothelial cell activation","volume":"27","author":"Wilhelmi","year":"2005","journal-title":"Eur J Cardiothorac Surg"},{"key":"B30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000006995","article-title":"Soluble vcam-1 and E-selectin, but not icam-1 discriminate endothelial injury in patients with documented coronary artery disease","volume":"93","author":"Semaan","year":"2000","journal-title":"Cardiology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2017.0064","article-title":"Association between vascular cell adhesion molecule 1 and atrial fibrillation","volume":"2","author":"Willeit","year":"2017","journal-title":"JAMA Cardiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19041057","article-title":"Emerging roles of vascular cell adhesion molecule-1 (Vcam-1) in immunological disorders and cancer","volume":"19","author":"Kong","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00115.x","article-title":"Ages bind to mesothelial cells via rage and stimulate vcam-1 expression","volume":"61","author":"Boulanger","year":"2002","journal-title":"Kidney Int"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201701536R","article-title":"Endothelial micrornas regulating the nf-\u03bab pathway and cell adhesion molecules during inflammation","volume":"32","author":"Zhong","year":"2018","journal-title":"FASEB J"},{"key":"B35","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.molcel.2017.09.024","article-title":"Pten regulates pi(3,4)P2 signaling downstream of class I pi3k","volume":"68","author":"Malek","year":"2017","journal-title":"Mol Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/nature19834","article-title":"Pi3k\u03b3 Is a molecular switch that controls immune suppression","volume":"539","author":"Kaneda","year":"2016","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-14-3303","article-title":"Manic fringe promotes a claudin-low breast cancer phenotype through notch-mediated pik3cg induction","volume":"75","author":"Zhang","year":"2015","journal-title":"Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.S250171","article-title":"Targeting pik3cg in combination with paclitaxel as a potential therapeutic regimen in claudin-low breast cancer","volume":"12","author":"Chang","year":"2020","journal-title":"Cancer Manag Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2020.07.013","article-title":"Pik3cg is a potential therapeutic target in androgen receptor-indifferent metastatic prostate cancer","volume":"190","author":"Chung","year":"2020","journal-title":"Am J Pathol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add0960","article-title":"Tead4 is a master regulator of high-risk nasopharyngeal carcinoma","volume":"9","author":"Wang","year":"2023","journal-title":"Sci Adv"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14266","article-title":"Bzw2 gene knockdown induces cell growth inhibition, G1 arrest and apoptosis in muscle-invasive bladder cancers: A microarray pathway analysis","volume":"23","author":"Gao","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw559","article-title":"Overexpression of eif5 or its protein mimic 5mp perturbs eif2 function and induces atf4 translation through delayed re-initiation","volume":"44","author":"Kozel","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28331","article-title":"Role of the novel gene bzw2 in the development of hepatocellular carcinoma","volume":"234","author":"Jin","year":"2019","journal-title":"J Cell Physiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ebiom.2019.05.058","article-title":"Novel oncogene 5mp1 reprograms C-myc translation initiation to drive Malignant phenotypes in colorectal cancer","volume":"44","author":"Sato","year":"2019","journal-title":"EBioMedicine"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.02.052","article-title":"Molecular landscape of the ribosome pre-initiation complex during mrna scanning: structural role for eif3c and its control by eif5","volume":"18","author":"Obayashi","year":"2017","journal-title":"Cell Rep"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.7150\/jca.53282","article-title":"Bzw2\/5mp1 acts as a promising target in hepatocellular carcinoma","volume":"12","author":"Li","year":"2021","journal-title":"J Cancer"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.26","article-title":"Bach transcription factors in innate and adaptive immunity","volume":"17","author":"Igarashi","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00868-7","article-title":"Bach2 enforces the transcriptional and epigenetic programs of stem-like cd8+ T cells","volume":"22","author":"Yao","year":"2021","journal-title":"Nat Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e20211476","DOI":"10.1084\/jem.20211476","article-title":"Bach2 restricts nk cell maturation and function, limiting immunity to cancer metastasis","volume":"219","author":"Imianowski","year":"2022","journal-title":"J Exp Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2012.01112.x","article-title":"Roles of bcl6 in normal and transformed germinal center B cells","volume":"247","author":"Basso","year":"2012","journal-title":"Immunol Rev"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2007.12.026","article-title":"Structure of a bcor corepressor peptide in complex with the bcl6 btb domain dimer","volume":"29","author":"Ghetu","year":"2008","journal-title":"Mol Cell"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.07.059","article-title":"The bcl6 rd2 domain governs commitment of activated B cells to form germinal centers","volume":"8","author":"Huang","year":"2014","journal-title":"Cell Rep"},{"key":"B53","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/humupd\/dmac027","article-title":"Bcl6, a key oncogene, in the placenta, pre-eclampsia and endometriosis","volume":"28","author":"Louwen","year":"2022","journal-title":"Hum Reprod Update"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.7150\/thno.56141","article-title":"Distinct placental molecular processes associated with early-onset and late-onset preeclampsia","volume":"11","author":"Ren","year":"2021","journal-title":"Theranostics"},{"key":"B55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cytogfr.2017.08.002","article-title":"Immunobiology of the il-15\/il-15r\u03b1 Complex as an antitumor and antiviral agent","volume":"38","author":"Guo","year":"2017","journal-title":"Cytokine Growth Factor Rev"},{"key":"B56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1146\/annurev.immunol.17.1.19","article-title":"The multifaceted regulation of interleukin-15 expression and the role of this cytokine in nk cell differentiation and host response to intracellular pathogens","volume":"17","author":"Waldmann","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2001.tb143728.x","article-title":"Environment, sustainability and health: the learning curve steepens","volume":"175","author":"McMichael","year":"2001","journal-title":"Med J Aust"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-1957","article-title":"Il-15 enhances survival and function of hiv-specific cd8+ T cells","volume":"101","author":"Mueller","year":"2003","journal-title":"Blood"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20060894","article-title":"Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in hiv-1 infection","volume":"203","author":"Mavilio","year":"2006","journal-title":"J Exp Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.158.12.5978","article-title":"Il-15 enhances immune functions during hiv infection","volume":"158","author":"Chehimi","year":"1997","journal-title":"J Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1086\/368222","article-title":"Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function","volume":"187","author":"Kottilil","year":"2003","journal-title":"J Infect Dis"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000014","article-title":"Filamin A: key actor in platelet biology","volume":"134","author":"Rosa","year":"2019","journal-title":"Blood"},{"key":"B63","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13023-015-0331-9","article-title":"47 patients with flna associated periventricular nodular heterotopia","volume":"10","author":"Lange","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"B64","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1161\/circulationaha.119.039697","article-title":"Targeting filamin a reduces macrophage activity and atherosclerosis","volume":"140","author":"Bandaru","year":"2019","journal-title":"Circulation"},{"key":"B65","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3109\/10428194.2011.605190","article-title":"The role of cd40\/cd40l and interferon regulatory factor 4 in hodgkin lymphoma microenvironment","volume":"53","author":"Aldinucci","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-19-1167","article-title":"Recent advances targeting ccr5 for cancer and its role in immuno-oncology","volume":"79","author":"Jiao","year":"2019","journal-title":"Cancer Res"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071765","article-title":"The ccl5\/ccr5 axis in cancer progression","volume":"12","author":"Aldinucci","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2022.12.354","article-title":"Immunophenotypic and genomic landscape of richter transformation diffuse large B-cell lymphoma","volume":"55","author":"El Hussein","year":"2023","journal-title":"Pathology"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3390\/cells13221839","article-title":"Association of genomic alterations with the presence of serum monoclonal proteins in chronic lymphocytic leukemia","volume":"13","author":"Pineyroa","year":"2024","journal-title":"Cells"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024013327","article-title":"Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes","volume":"8","author":"Charalampopoulou","year":"2024","journal-title":"Blood Adv"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1376660","article-title":"Mouse models of chronic lymphocytic leukemia and richter transformation: what we have learnt and what we are missing","volume":"15","author":"Bertilaccio","year":"2024","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2023.102165","article-title":"Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through crispr-cas9 gene editing","volume":"4","author":"Ten Hacken","year":"2023","journal-title":"STAR Protoc"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2016.11.011","article-title":"Pi3k signaling pathway in normal B cells and indolent B-cell Malignancies","volume":"43","author":"Pongas","year":"2016","journal-title":"Semin Oncol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2018.01.002","article-title":"Targeting the B-cell receptor pathway in diffuse large B-cell lymphoma","volume":"65","author":"Dunleavy","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1141208","article-title":"The role of interleukin-15 in the development and treatment of hematological Malignancies","volume":"14","author":"Sindaco","year":"2023","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1184703","article-title":"Research progress of interleukin-15 in cancer immunotherapy","volume":"14","author":"Cai","year":"2023","journal-title":"Front Pharmacol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1516946\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T06:54:58Z","timestamp":1740466498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1516946\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":76,"alternative-id":["10.3389\/fimmu.2025.1516946"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1516946","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"article-number":"1516946"}}